Rekombinanter SLC45A3 Antikörper (N-Term)
Kurzübersicht für Rekombinanter SLC45A3 Antikörper (N-Term) (ABIN7879655)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- Recombinant Prostein Antibody / SLC45A3 (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A synthesized peptide corresponding to the N terminus of the human protein was used as the immunogen for the recombinant Prostein antibody.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant Prostein antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the recombinant Prostein antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))
-
Andere Bezeichnung
- Prostein
-
Hintergrund
- Human prostein is a 553 aa protein identified by cDNA library subtraction and subsequent high throughput microarray screening of prostate cancer. Prostein has multiple transmembrane domains. Prostein has been shown to be uniquely expressed in normal and cancerous prostatic tissues. By immunohistochemistry, prostein is expressed in the vast majority of normal and malignant prostatic tissues, regardless of grade and metastatic status. No protein expression is detected in normal and malignant tissue samples representing the great majority of essential tissues and tumors. In particular, prostein is expressed in most of poorly differentiated prostatic carcinoma, including small cell prostate carcinoma. Prostein is more specific and sensitive for prostatic carcinomas than PSA and PSAP.
-
UniProt
- Q96JT2
Target
-